Epidemiology of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus, Fifth Edition

Volumn , Issue , 2010, Pages 673-696

  Duarte, Catia ^a   Couto, Maura ^b   Ines, Luis ^c   Liang, Matthew H ^d  

^a Rheumatology Department   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c Rheumatology Department Coimbra University Hospital   (Portugal)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890934884     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374994-9.10036-1     Document Type: Chapter

References (242)

1. O. Nived and G. Sturfelt (1987) Epidemiology of systemic lupus erythematosus. Monogr Allergy 21 197-214.
2. A.S. Cohen, W.E. Reynolds, E.C. Franklin, J.P. Kulka, M.W. Ropes, L.E. Shulman, et al. (1971) Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 21 643-648.
3. E.M. Tan, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 1271-1277.
4. J.F. Fries (1987) Methodology of validation of criteria for SLE. Scand J Rheumatol Suppl 65 25-30.
5. C.M. Passas, R.L. Wong, M. Peterson, M.A. Testa and N.F. Rothfield (1985) A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 28 620-623.
6. R.E. Levin, A. Weinstein, M. Peterson, M.A. Testa and N.F. Rothfield (1984) A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 27 530-538.
7. R. Yokohari and T. Tsunematsu (1985) Application, to Japanese patients, of the 1982 American Rheumatism Association revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 28 693-698.
8. J.D. Clough, M. Elrazak, L.H. Calabrese, R. Valenzuela, W.B. Braun and G.W. Williams (1984) Weighted criteria for the diagnosis of systemic lupus erythematosus. Arch Intern Med 144 281-285.
9. K.H. Costenbader, E.W. Karlson and L.A. Mandl (2002) Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus. J Rheumatol 29 2545-2550.
10. M.L. Sanchez, G.S. Alarcon, G. McGwin Jr., B.J. Fessler and R.P. Kimberly (2003) Can the weighted criteria improve our ability to capture a larger number of lupus patients into observational and interventional studies? A comparison with the American College of Rheumatology criteria. Lupus 12 468-470.
11. E.L. Smith and R.H. Shmerling (1999) The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 8 586-595.
12. R.C. Lawrence, C.G. Helmick, F.C. Arnett, R.A. Deyo, D.T. Felson, E.H. Giannini, et al. (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41 778-799.
13. N. Danchenko, J.A. Satia and M.S. Anthony (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15 308-318.
14. G.J. Pons-Estel, G.S. Alarcon, L. Scofield, L. Reinlib and G.S. Cooper (2010) Understanding the epidemiology and progression of Systemic Lupus Erythematosus. Semin Arthritis Rheum 39 257-268.
15. S. Bernatsky, L. Joseph, C.A. Pineau, R. Tamblyn, D.E. Feldman and A.E. Clarke (2007) A population-based assessment of systemic lupus erythematosus incidence and prevalence–results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 46 1814-1818.
16. M. Siegel and S.L. Lee (1973) The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 3 1-54.
17. M. Siegel, H.L. Holley and S.L. Lee (1970) Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama. 1956-1965, Arthritis Rheum 13 802-811.
18. M. Siegel, S.L. Lee, D. Widelock, G.J. Reillyeb, Wise, S.B. Zingale and H.T. Fuerst (1962) The epidemiology of systemic lupus erythematosus: preliminary results in New York City. J Chronic Dis 15 131-140.
19. C.J. Michet Jr., C.H. McKenna, L.R. Elveback, R.A. Kaslow and L.T. Kurland (1985) Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota. 1950 through [1979] Mayo Clin Proc 60 105-113.
20. D.J. McCarty, S. Manzi, T.A. Medsger Jr., R. Ramsey-Goldman, R.E. LaPorte and C.K. Kwoh (1995) Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 38 1260-1270.
21. M.C. Hochberg (1985) The incidence of systemic lupus erythematosus in Baltimore, Maryland. 1970-1977, Arthritis Rheum 28 80-86.
22. A.L. Naleway, M.E. Davis, R.T. Greenlee, D.A. Wilson and D.J. McCarty (2005) Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 14 862-866.
23. K.M. Uramoto, C.J. Michet Jr., J. Thumboo, J. Sunku, W.M. O’Fallon and S.E. Gabriel (1999) Trends in the incidence and mortality of systemic lupus erythematosus. 1950-[1992] Arthritis Rheum 42 46-50.
24. C.A. Peschken and J.M. Esdaile (2000) Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 27 1884-1891.
25. O. Nived, G. Sturfelt and F. Wollheim (1985) Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol 24 147-154.
26. H. Jonsson, O. Nived, G. Sturfelt and A. Silman (1990) Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol 29 185-188.
27. C. Stahl-Hallengren, A. Jonsen, O. Nived and G. Sturfelt (2000) Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 27 685-691.
28. N.D. Hopkinson, M. Doherty and R.J. Powell (1993) The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK. 1989-[1990] Br J Rheumatol 32 110-115.
29. A.L. Nightingale, R.D. Farmer and C.S. de Vries (2006) Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 15 656-661.
30. S. Gudmundsson and K. Steinsson (1990) Systemic lupus erythematosus in Iceland 1975 through [1984] A nationwide epidemiological study in an unselected population. J Rheumatol 17 1162-1167.
31. H.C. Nossent (2001) Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 28 539-546.
32. P. Lopez, L. Mozo, C. Gutierrez and A. Suarez (2003) Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 12 860-865.
33. M. Govoni, G. Castellino, S. Bosi, N. Napoli and F. Trotta (2006) Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. Lupus 15 110-113.
34. H. Laustrup, A. Voss, A. Green and P. Junker (2009) Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol 38 128-132.
35. Y. Alamanos, P.V. Voulgari, C. Siozos, P. Katsimpri, S. Tsintzos, G. Dimou, et al. (2003) Epidemiology of systemic lupus erythematosus in northwest Greece 1982-[2001] J Rheumatol 30 731-735.
36. N.M. Anstey, I. Bastian, H. Dunckley and B.J. Currie (1995) Systemic lupus erythematosus (SLE): different prevalences in different populations of Australian aborigines. Aust N Z J Med 25 736.
37. K. Iseki, F. Miyasato, T. Oura, H. Uehara, K. Nishime and K. Fukiyama (1994) An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 23 547-554.
38. M.J. Vilar and E.I. Sato (2002) Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus 11 528-532.
39. C.C. Mok, C.H. To, L.Y. Ho and K.L. Yu (2008) Incidence and mortality of systemic lupus erythematosus in a southern Chinese population. 2000-2006, J Rheumatol 35 1978-1982.
40. E.F. Chakravarty, T.M. Bush, S. Manzi, A.E. Clarke and M.M. Ward (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56 2092-2094.
41. T. Helve (1985) Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 14 43-46.
42. M.C. Hochberg (1987) Prevalence of systemic lupus erythematosus in England and Wales. 1981-2, Ann Rheum Dis 46 664-666.
43. G.O. Eilertsen, A. Becker-Merok and J.C. Nossent (2009) The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management. J Rheumatol 36 552-559.
44. J.C. Nossent (1992) Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation. Ann Rheum Dis 51 1197-1201.
45. M. Segasothy and P.A. Phillips (2001) Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus 10 439-444.
46. D.M. Grennan and D. Bossingham (1995) Systemic lupus erythematosus (SLE): different prevalences in different populations of Australian aboriginals. Aust N Z J Med 25 182-183.
47. C. Deligny, L. Thomas, F. Dubreuil, C. Theodose, A.M. Garsaud, P. Numeric, et al. (2002) Systemic lupus erythematosus in Martinique: an epidemiologic study. Rev Med Interne 23 21-29.
48. M. Siegel, E.B. Reilly, S.L. Lee, H.T. Fuerst and M. Seelenfreund (1964) Epidemiology of systemic lupus erythematosus: Time trend and racial differences. Am J Public Health Nations Health 54 33-43.
49. R. Cervera, M.A. Khamashta, J. Font, G.D. Sebastiani, A. Gil, P. Lavilla, et al. (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82 299-308.
50. B.A. Pons-Estel, L.J. Catoggio, M.H. Cardiel, E.R. Soriano, S. Gentiletti, A.R. Villa, et al. (2004) The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics,”. Medicine (Baltimore) 83 1-17.
51. E.M. Ginzler, H.S. Diamond, M. Weiner, M. Schlesinger, J.F. Fries, C. Wasner, et al. (1982) A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 25 601-611.
52. E.C. Somers, S.L. Thomas, L. Smeeth, W.M. Schoonen and A.J. Hall (2007) Incidence of systemic lupus erythematosus in the United Kingdom. 1990-[1999] Arthritis Rheum 57 612-618.
53. C. Huemer, M. Huemer, T. Dorner, J. Falger, H. Schacherl, M. Bernecker, et al. (2001) Incidence of pediatric rheumatic diseases in a regional population in Austria. J Rheumatol 28 2116-2119.
54. P.M. Pelkonen, H.J. Jalanko, R.K. Lantto, A.L. Makela, M.A. Pietikainen, H.A. Savolainen, et al. (1994) Incidence of systemic connective tissue diseases in children: a nationwide prospective study in Finland. J Rheumatol 21 2143-2146.
55. P.N. Malleson, M.Y. Fung and A.M. Rosenberg (1996) The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 23 1981-1987.
56. S. Fujikawa and M. Okuni (1997) A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn 39 242-244.
57. J.L. Huang, T.C. Yao and L.C. See (2004) Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 22 776-780.
58. K.M. Houghton, J. Page, D.A. Cabral, R.E. Petty and L.B. Tucker (2006) Systemic lupus erythematosus in the pediatric North American Native population of British Columbia. J Rheumatol 33 161-163.
59. N.D. Hopkinson, M. Doherty and R.J. Powell (1994) Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 53 675-680.
60. A.E. Johnson, C. Gordon, R.G. Palmer and P.A. Bacon (1995) The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 38 551-558.
61. D.P. Symmons (1995) Frequency of lupus in people of African origin. Lupus 4 176-178.
62. S.C. Bae, P. Fraser and M.H. Liang (1998) The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the “prevalence gradient hypothesis,”. Arthritis Rheum 41 2091-2099.
63. M.K. Serdula and G.G. Rhoads (1979) Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 22 328-333.
64. H.H. Hart, R.R. Grigor and D.E. Caughey (1983) Ethnic difference in the prevalence of systemic lupus erythematosus. Ann Rheum Dis 42 529-532.
65. A. Samanta, J. Feehally, S. Roy, F.E. Nichol, P.J. Sheldon and J. Walls (1991) High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 50 490-492.
66. G.S. Boyer, D.W. Templin and A.P. Lanier (1991) Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 18 1477-1484.
67. G.S. Cooper, M.A. Dooley, E.L. Treadwell, E.W. St Clair, C.G. Parks and G.S. Gilkeson (1998) Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 41 1714-1724.
68. Z.M. Sthoeger, Z. Bentwich, H. Zinger and E. Mozes (1994) The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus. J Rheumatol 21 2231-2238.
69. L.A. Criswell (2008) The genetic contribution to systemic lupus erythematosus. Bull NYU Hosp Jt Dis 66 176-183.
70. R. Priori, E. Medda, F. Conti, E.A. Cassara, M.G. Danieli, R. Gerli, et al. (2003) Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. Lupus 12 735-740.
71. C. Nagata, S. Fujita, H. Iwata, Y. Kurosawa, K. Kobayashi, M. Kobayashi, et al. (1995) Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol 34 333-337.
72. G.S. Cooper, M.A. Dooley, E.L. Treadwell, E.W. St Clair and G.S. Gilkeson (2002) Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. J Clin Epidemiol 55 982-989.
73. A.A. Bengtsson, L. Rylander, L. Hagmar, O. Nived and G. Sturfelt (2002) Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 41 563-571.
74. S. Koskenmies, E. Widen, J. Kere and H. Julkunen (2001) Familial systemic lupus erythematosus in Finland. J Rheumatol 28 758-760.
75. H.M. Yeh, J.R. Chen, J.J. Tsai, W.J. Tsai, J.H. Yen and H.W. Liu (1993) Prevalence of familial systemic lupus erythematosus in Taiwan. Gaoxiong Yi Xue Ke Xue Za Zhi 9 664-667.
76. J. Wang, S. Yang, J.J. Chen, S.M. Zhou, S.M. He, Y.H. Liang, et al. (2007) Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. Arch Dermatol Res 298 485-491.
77. J.S. Lawrence, C.L. Martins and G.L. Drake (1987) A family survey of lupus erythematosus. [1] Heritability. J Rheumatol 14 913-921.
78. D. Deapen, A. Escalante, L. Weinrib, D. Horwitz, B. Bachman, P. Roy-Burman, et al. (1992) A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35 311-318.
79. S.R. Block, J.B. Winfield, M.D. Lockshin, W.A. D’Angelo and C.L. Christian (1975) Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 59 533-552.
80. I.T. Harley, K.M. Kaufman, C.D. Langefeld, J.B. Harley and J.A. Kelly (2009) Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 10 285-290.
81. J.R. Roubinian, R. Papoian and N. Talal (1977) Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest 59 1066-1070.
82. H. Carlsten, A. Tarkowski, R. Holmdahl and L.A. Nilsson (1990) Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol 80 467-473.
83. G. Kokeny, M. Godo, E. Nagy, M. Kardos, K. Kotsch, P. Casalis, et al. (2007) Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. Lupus 16 465-477.
84. Y.Y. Dhaher, B. Greenstein, E. de Fougerolles Nunn, M. Khamashta and G.R. Hughes (2000) Strain differences in binding properties of estrogen receptors in immature and adult BALB/c and MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus. Int J Immunopharmacol 22 247-254.
85. K.K. Bynote, J.M. Hackenberg, K.S. Korach, D.B. Lubahn, P.H. Lane and K.A. Gould (2008) Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW) F1 mice. Genes Immun 9 137-152.
86. B. Greenstein, R. Roa, Y. Dhaher, E. Nunn, A. Greenstein, M. Khamashta, et al. (2001) Estrogen and progesterone receptors in murine models of systemic lupus erythematosus. Int Immunopharmacol 1 1025-1035.
87. M. Blank, S. Mendlovic, H. Fricke, E. Mozes, N. Talal and Y. Shoenfeld (1990) Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice. J Rheumatol 17 311-317.
88. R.G. Lahita, H.L. Bradlow, E. Ginzler, S. Pang and M. New (1987) Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 30 241-248.
89. R.G. Lahita, H.L. Bradlow, H.G. Kunkel and J. Fishman (1979) Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 22 1195-1198.
90. M. Folomeev, M. Dougados, J. Beaune, J.C. Kouyoumdjian, K. Nahoul, B. Amor, et al. (1992) Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1 191-195.
91. P. Jungers, K. Nahoul, C. Pelissier, M. Dougados, N. Athea, F. Tron, et al. (1983) Plasma androgens in women with disseminated lupus erythematosus. Presse Med 12 685-688.
92. C. Lavalle, E. Loyo, R. Paniagua, J.A. Bermudez, J. Herrera, A. Graef, et al. (1987) Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 14 268-272.
93. K.H. Costenbader, D. Feskanich, M.J. Stampfer and E.W. Karlson (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56 1251-1262.
94. G.S. Cooper, M.A. Dooley, E.L. Treadwell, E.W. St Clair and G.S. Gilkeson (2002) Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum 46 1830-1839.
95. J. Sanchez-Guerrero, E.W. Karlson, M.H. Liang, D.J. Hunter, F.E. Speizer and G.A. Colditz (1997) Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 40 804-808.
96. J. Sanchez-Guerrero, M.H. Liang, E.W. Karlson, D.J. Hunter and G.A. Colditz (1995) Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 122 430-433.
97. E. Peeva, J. Venkatesh, D. Michael and B. Diamond (2004) Prolactin as a modulator of B cell function: implications for SLE. Biomed Pharmacother 58 310-319.
98. R. McMurray, D. Keisler, S. Izui and S.E. Walker (1994) Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 71 338-343.
99. R. McMurray, D. Keisler, K. Kanuckel, S. Izui and S.E. Walker (1991) Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 147 3780-3787.
100. R.W. McMurray, D. Keisler, S. Izui and S.E. Walker (1993) Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. J Rheumatol 20 1143-1151.
101. E. Peeva, C. Grimaldi, L. Spatz and B. Diamond (2000) Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest 106 1373-1379.
102. Z. Rezaieyazdi and A. Hesamifard (2006) Correlation between serum prolactin levels and lupus activity. Rheumatol Int 26 1036-1039.
103. M. Pacilio, S. Migliaresi, R. Meli, L. Ambrosone, B. Bigliardo and R. Di Carlo (2001) Elevated bioactive prolactin levels in systemic lupus erythematosus–association with disease activity. J Rheumatol 28 2216-2221.
104. A.M. Jacobi, W. Rohde, M. Ventz, G. Riemekasten, G.R. Burmester and F. Hiepe (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10 554-561.
105. C.C. Mok, C.S. Lau and S.C. Tam (1997) Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients. Br J Rheumatol 36 986-989.
106. P. Jimena, M.A. Aguirre, A. Lopez-Curbelo, M. de Andres, C. Garcia-Courtay and M.J. Cuadrado (1998) Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. Lupus 7 383-386.
107. A. Leanos-Miranda and G. Cardenas-Mondragon (2006) Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford) 45 97-101.
108. J.B. Harley, I.T. Harley, J.M. Guthridge and J.A. James (2006) The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 15 768-777.
109. C.G. Parks, G.S. Cooper, L.L. Hudson, M.A. Dooley, E.L. Treadwell, E.W. St Clair, et al. (2005) Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52 1148-1159.
110. J.J. Lu, D.Y. Chen, C.W. Hsieh, J.L. Lan, F.J. Lin and S.H. Lin (2007) Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 16 168-175.
111. J.A. James, B.R. Neas, K.L. Moser, T. Hall, G.R. Bruner, A.L. Sestak, et al. (2001) Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 44 1122-1126.
112. H. Kitagawa, S. Iho, T. Yokochi and T. Hoshino (1988) Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Immunol Lett 17 249-252.
113. C.J. Chen, K.H. Lin, S.C. Lin, W.C. Tsai, J.H. Yen, S.J. Chang, et al. (2005) High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol 32 44-47.
114. J.A. James, K.M. Kaufman, A.D. Farris, E. Taylor-Albert, T.J. Lehman and J.B. Harley (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100 3019-3026.
115. M.T. McClain, B.D. Poole, B.F. Bruner, K.M. Kaufman, J.B. Harley and J.A. James (2006) An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum 54 360-368.
116. H. Bezanahary, R. Inaoui, V. Allot, K. Ly, S. Rogez, E. Liozon, et al. (2002) Systemic lupus erythematosus and herpes virus infection: three new observations. Rev Med Interne 23 1018-1021.
117. M. Nawata, N. Seta, M. Yamada, I. Sekigawa, N. Lida and H. Hashimoto (2001) Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. Scand J Rheumatol 30 360-362.
118. S. Akagi, H. Ichikawa, J. Suzuki and H. Makino (2004) Systemic lupus erythematosus associated with cytomegalovirus infection. Scand J Rheumatol 33 58-59.
119. I. Sekigawa, M. Nawata, N. Seta, M. Yamada, N. Iida and H. Hashimoto (2002) Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol 20 559-564.
120. J.R. Rider, W.E. Ollier, R.J. Lock, S.T. Brookes and D.H. Pamphilon (1997) Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 15 405-409.
121. M. Ramos-Casals, M.J. Cuadrado, P. Alba, G. Sanna, P. Brito-Zeron, L. Bertolaccini, et al. (2008) Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 87 311-318.
122. A. Bengtsson, A. Widell, S. Elmstahl and G. Sturfelt (2000) No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B[19], Ann Rheum Dis 59 64-66.
123. B.L. Strom, M.M. Reidenberg, S. West, E.S. Snyder, B. Freundlich and P.D. Stolley (1994) Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 140 632-642.
124. J.E. Pope, A. Krizova, J.M. Ouimet, J.L. Goodwin and M. Lankin (2004) Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory nusculoskeletal disorders. J Rheumatol 31 274-279.
125. L.F. Ayvazian and T.L. Badger (1948) Disseminated lupus erythematosus occurring among student nurses. N Engl J Med 239 565-570.
126. S.A. Older, D.F. Battafarano, R.J. Enzenauer and A.M. Krieg (1999) Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum 29 131-139.
127. A. Choffray, L. Pinquier and H. Bachelez (2007) Exacerbation of lupus panniculitis following anti-hepatitis-B vaccination. Dermatology 215 152-154.
128. D. Santoro, M. Stella, G. Montalto and S. Castellino (2007) Lupus nephritis after hepatitis B vaccination: an uncommon complication. Clin Nephrol 67 61-63.
129. M.R. Geier and D.A. Geier (2004) A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 22 749-755.
130. Y. Kuroda, J. Akaogi, D.C. Nacionales, S.C. Wasdo, N.J. Szabo, W.H. Reeves, et al. (2004) Distinctive patterns of autoimmune response induced by different types of mineral oil. Toxicol Sci 78 222-228.
131. Y. Kuroda, D.C. Nacionales, J. Akaogi, W.H. Reeves and M. Satoh (2004) Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 58 325-337.
132. P.B. Asa, Y. Cao and R.F. Garry (2000) Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol 68 55-64.
133. M.K. Kuechle and K.B. Elkon (2007) Shining light on lupus and UV. Arthritis Res Ther 9 101.
134. E. Reefman, H. Kuiper, M.F. Jonkman, P.C. Limburg, C.G. Kallenberg and M. Bijl (2006) Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes. Rheumatology (Oxford) 45 538-544.
135. M. Ghoreishi and J.P. Dutz (2009) Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev 8 484-487.
136. H. McGrath Jr. (1994) Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 12 129-135.
137. H. McGrath Jr. (1999) Ultraviolet A1 (340-400 nm) irradiation and systemic lupus erythematosus. J Investig Dermatol Symp Proc 4 79-84.
138. K.H. Costenbader, D.J. Kim, J. Peerzada, S. Lockman, D. Nobles-Knight, M. Petri, et al. (2004) Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 50 849-857.
139. C.J. Hardy, B.P. Palmer, K.R. Muir, A.J. Sutton and R.J. Powell (1998) Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study. Ann Rheum Dis 57 451-455.
140. C. Kiyohara, M. Washio, T. Horiuchi, Y. Tada, T. Asami, S. Ide, et al. (2009) Cigarette Smoking, STAT4 and TNFRSF[1] B Polymorphisms, and Systemic Lupus Erythematosus in a Japanese Population. J Rheumatol 18 630-638.
141. J. Wang, H.F. Pan, D.Q. Ye, H. Su and X.P. Li (2008) Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis. Clin Rheumatol 27 1557-1563.
142. L.W. Freni-Titulaer, D.B. Kelley, A.G. Grow, T.W. McKinley, F.C. Arnett and M.C. Hochberg (1989) Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol 130 404-409.
143. G.S. Cooper, M.A. Dooley, E.L. Treadwell, E.W. St Clair and G.S. Gilkeson (2001) Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol 28 2653-2656.
144. C.J. Hardy, B.P. Palmer, K.R. Muir and R.J. Powell (1999) Systemic lupus erythematosus (SLE) and hair treatment: a large community based case-control study. Lupus 8 541-544.
145. M. Petri and J. Allbritton (1992) Hair product use in systemic lupus erythematosus. A case-control study. Arthritis Rheum 35 625-629.
146. J. Sanchez-Guerrero, E.W. Karlson, G.A. Colditz, D.J. Hunter, F.E. Speizer and M.H. Liang (1996) Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum 39 657-662.
147. C.G. Parks, K. Conrad and G.S. Cooper (1999) Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 5(107 Suppl), 793-802.
148. J.M. Brown, A.J. Archer, J.C. Pfau and A. Holian (2003) Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol 131 415-421.
149. J.C. Pfau, J.M. Brown and A. Holian (2004) Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 195 167-176.
150. K. Conrad, J. Mehlhorn, K. Luthke, T. Dorner and K.H. Frank (1996) Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus 5 62-69.
151. C.G. Parks, G.S. Cooper, L.A. Nylander-French, W.T. Sanderson, J.M. Dement, P.L. Cohen, et al. (2002) Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum 46 1840-1850.
152. A. Finckh, G.S. Cooper, L.B. Chibnik, K.H. Costenbader, J. Watts, H. Pankey, et al. (2006) Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum 54 3648-3654.
153. E.C. Janowsky, L.L. Kupper and B.S. Hulka (2000) Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342 781-790.
154. G.S. Cooper, C.G. Parks, E.L. Treadwell, E.W. St Clair, G.S. Gilkeson and M.A. Dooley (2004) Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 31 1928-1933.
155. E.W. Karlson, J. Watts, J. Signorovitch, M. Bonetti, E. Wright, G.S. Cooper, et al. (2007) Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury lupus project. Arthritis Rheum 56 244-254.
156. M. Petri, J. Buyon and M. Kim (1999) Classification and definition of major flares in SLE clinical trials. Lupus 8 685-691.
157. M. Petri, M. Genovese, E. Engle and M. Hochberg (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34 937-944.
158. H. Jonsson, O. Nived and G. Sturfelt (1989) Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 68 141-150.
159. J.E. Weiss, C.P. Sison, N.T. Ilowite, B.S. Gottlieb and B.A. Eberhard (2007) Flares in pediatric systemic lupus erythematosus. J Rheumatol 34 1341-1344.
160. P.G. Vlachoyiannopoulos, F.B. Karassa, K.X. Karakostas, A.A. Drosos and H.M. Moutsopoulos (1993) Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus 2 303-312.
161. J.P. Buyon, M.A. Petri, M.Y. Kim, K.C. Kalunian, J. Grossman, B.H. Hahn, et al. (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142 953-962.
162. M. Petri, M.Y. Kim, K.C. Kalunian, J. Grossman, B.H. Hahn, L.R. Sammaritano, et al. (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353 2550-2558.
163. J. Sanchez-Guerrero, M. Gonzalez-Perez, M. Durand-Carbajal, P. Lara-Reyes, L. Jimenez-Santana, J. Romero-Diaz, et al. (2007) Menopause hormonal therapy in women with systemic lupus erythematosus. Arthritis Rheum 56 3070-3079.
164. J. Cortes-Hernandez, J. Ordi-Ros, F. Paredes, M. Casellas, F. Castillo and M. Vilardell-Tarres (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 41 643-650.
165. M. Petri, D. Howard and J. Repke (1991) Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 34 1538-1545.
166. G. Ruiz-Irastorza, F. Lima, J. Alves, M.A. Khamashta, J. Simpson, G.R. Hughes, et al. (1996) Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 35 133-138.
167. J. Leone, J.L. Pennaforte, V. Delhinger, J. Detour, K. Lefondre, J.P. Eschard, et al. (1997) Influence of seasons on risk of flare-up of systemic lupus: retrospective study of 66 patients. Rev Med Interne 18 286-291.
168. M. Amit, Y. Molad, S. Kiss and A.J. Wysenbeek (1997) Seasonal variations in manifestations and activity of systemic lupus erythematosus. Br J Rheumatol 36 449-452.
169. H.J. Haga, J.G. Brun, O.P. Rekvig and L. Wetterberg (1999) Seasonal variations in activity of systemic lupus erythematosus in a subarctic region. Lupus 8 269-273.
170. T. Hasan, M. Pertovaara, U. Yli-Kerttula, T. Luukkaala and M. Korpela (2004) Seasonal variation of disease activity of systemic lupus erythematosus in Finland: a 1 year follow up study. Ann Rheum Dis 63 1498-1500.
171. M.I. Peralta-Ramirez, J. Jimenez-Alonso, J.F. Godoy-Garcia and M. Perez-Garcia (2004) The effects of daily stress and stressful life events on the clinical symptomatology of patients with lupus erythematosus. Psychosom Med 66 788-794.
172. C.R. Pawlak, T. Witte, H. Heiken, M. Hundt, J. Schubert, B. Wiese, et al. (2003) Flares in patients with systemic lupus erythematosus are associated with daily psychological stress. Psychother Psychosom 72 159-165.
173. M.M. Ward, A.S. Marx and N.N. Barry (2002) Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology (Oxford) 41 184-188.
174. D. Gladman, E. Ginzler, C. Goldsmith, P. Fortin, M. Liang, M. Urowitz, et al. (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39 363-369.
175. G. Cassano, S. Roverano, S. Paira, V. Bellomio, E. Lucero, A. Berman, et al. (2007) Accrual of organ damage over time in Argentine patients with systemic lupus erythematosus: a multi-centre study. Clin Rheumatol 26 2017-2022.
176. C.C. Mok, C.T. Ho, R.W. Wong and C.S. Lau (2003) Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 30 1513-1519.
177. D.D. Gladman, M.B. Urowitz, P. Rahman, D. Ibanez and L.S. Tam (2003) Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30 1955-1959.
178. G.S. Alarcon, G. McGwin Jr., A.A. Bartolucci, J. Roseman, J. Lisse, B.J. Fessler, et al. (2001) Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 44 2797-2806.
179. A.J. Swaak, H.G. van den Brink, R.J. Smeenk, K. Manger, J.R. Kalden, S. Tosi, et al. (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford) 38 953-958.
180. S. Manzi, E.N. Meilahn, J.E. Rairie, C.G. Conte, T.A. Medsger Jr., L. Jansen-McWilliams, et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145 408-415.
181. I.N. Bruce (2005) ’Not only…but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 44 1492-1502.
182. J.M. Esdaile, M. Abrahamowicz, T. Grodzicky, Y. Li, C. Panaritis, R. du Berger, et al. (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44 2331-2337.
183. A. Zonana-Nacach, A. Camargo-Coronel, P. Yanez, L. Sanchez, F.J. Jimenez-Balderas and A. Fraga (2001) Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10 505-510.
184. X. Bosch, A. Guilabert, L. Pallares, R. Cerveral, M. Ramos-Casals, A. Bove, et al. (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15 584-589.
185. V. Noel, O. Lortholary, P. Casassus, P. Cohen, T. Genereau, M.H. Andre, et al. (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60 1141-1144.
186. S.J. Jeong, H. Choi, H.S. Lee, S.H. Han, B.S. Chin, J.H. Baek, et al. (2009) Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus. Scand J Infect Dis 41 268-274.
187. O. Nived, A. Bengtsson, A. Jonsen, G. Sturfelt and H. Olsson (2001) Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Lupus 10 500-504.
188. D.M. Sweeney, S. Manzi, J. Janosky, K.J. Selvaggi, W. Ferri, T.A. Medsger Jr., et al. (1995) Risk of malignancy in women with systemic lupus erythematosus. J Rheumatol 22 1478-1482.
189. T. Pettersson, E. Pukkala, L. Teppo and C. Friman (1992) Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 51 437-439.
190. S. Bernatsky, J.F. Boivin, L. Joseph, R. Rajan, A. Zoma, S. Manzi, et al. (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52 1481-1490.
191. K. McElhone, J. Abbott and L.S. Teh (2006) A review of health related quality of life in systemic lupus erythematosus. Lupus 15 633-643.
192. G. Ruiz-Irastorza, M. Ramos-Casals, P. Brito-Zeron and M.A. Khamashta (2009) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69 20-28.
193. M.F. Gordon, P.D. Stolley and R. Schinnar (1981) Trends in recent systemic lupus erythematosus mortality rates. Arthritis Rheum 24 762-769.
194. S. Bernatsky, J.F. Boivin, L. Joseph, S. Manzi, E. Ginzler, D.D. Gladman, et al. (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54 2550-2557.
195. M. Merrell and L.E. Shulman (1955) Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis 1 12-32.
196. M. Funauchi, H. Shimadzu, C. Tamaki, T. Yamagata, Y. Nozaki, M. Sugiyama, et al. (2007) Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center. Rheumatol Int 27 243-249.
197. N. Kasitanon, L.S. Magder and M. Petri (2006) Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 85 147-156.
198. M.B. Urowitz, D.D. Gladman, B.D. Tom, D. Ibanez and V.T. Farewell (2008) Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 35 2152-2158.
199. A. Ippolito and M. Petri (2008) An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol 26 S72-S79.
200. R.A. Kaslow and A.T. Masi (1978) Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum 21 473-479.
201. S.J. Walsh and L.M. DeChello (2001) Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus 10 637-646.
202. CDC (2002) Trends in Deaths from Systemic Lupus Erythematosus- United States. 1979-[1998] MMVR 51 371-373.
203. M.C. Hochberg (1987) Mortality from systemic lupus erythematosus in England and Wales. 1974-[1983] Br J Rheumatol 26 437-441.
204. S. Wadee, M. Tikly and M. Hopley (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 46 1487-1491.
205. F.J. Blanco, J.J. Gomez-Reino, J. de la Mata, A. Corrales, V. Rodriguez-Valverde, J.C. Rosas, et al. (1998) Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 7 159-163.
206. G.S. Alarcón, G. McGwin Jr., H.M. Bastian, J. Roseman, J. Lisse, B.J. Fessler, et al. (2001) Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 45 191-202.
207. C.C. Mok, A. Mak, W.P. Chu, C.H. To and S.N. Wong (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 84 218-224.
208. E. Krishnan and H.B. Hubert (2006) Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis 65 1500-1505.
209. M. Fernandez, G.S. Alarcón, J. Calvo-Alen, R. Andrade, G. McGwin Jr., L.M. Vila, et al. (2007) A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 57 576-584.
210. M.M. Ward (2004) Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum 51 616-624.
211. A.M. Bertoli, G.S. Alarcón, J. Calvo-Alen, M. Fernandez, L.M. Vila and J.D. Reveille (2006) Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum 54 1580-1587.
212. S. Bujan, J. Ordi-Ros, J. Paredes, M. Mauri, L. Matas, J. Cortes, et al. (2003) Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients. Ann Rheum Dis 62 859-865.
213. V. Bellomio, A. Spindler, E. Lucero, A. Berman, M. Santana, C. Moreno, et al. (2000) Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus 9 377-381.
214. A. Zonana-Nacach, P. Yanez, F.J. Jimenez-Balderas and A. Camargo-Coronel (2007) Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Lupus 16 997-1000.
215. J. Nossent, N. Cikes, E. Kiss, A. Marchesoni, V. Nassonova, M. Mosca, et al. (2007) Current causes of death in systemic lupus erythematosus in Europe, 2000–2004: relation to disease activity and damage accrual. Lupus 16 309-317.
216. M.B. Urowitz, A.A. Bookman, B.E. Koehler, D.A. Gordon, H.A. Smythe and M.A. Ogryzlo (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60 221-225.
217. A. Doria, L. Iaccarino, A. Ghirardello, S. Zampieri, S. Arienti, P. Sarzi-Puttini, et al. (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119 700-706.
218. L. Bjornadal, L. Yin, F. Granath, L. Klareskog and A. Ekbom (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. J Rheumatol 31 713-719.
219. M.B. Urowitz, D.D. Gladman, M. Abu-Shakra and V.T. Farewell (1997) Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol 24 1061-1065.
220. M. Abu-Shakra, M.B. Urowitz, D.D. Gladman and J. Gough (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22 1259-1264.
221. A.S. Al-Arfaj, S.R. Al-Balla, A.N. Al-Dalaan, S.S. Al-Saleh, S.A. Bahabri, M.M. Mousa, et al. (2002) Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J 23 87-89.
222. D.J. Wallace, T. Podell, J. Weiner, J.R. Klinenberg, S. Forouzesh and E.L. Dubois (1981) Systemic lupus erythematosus–survival patterns. Experience with 609 patients. JAMA 245 934-938.
223. A.J. Swaak, J.C. Nossent, W. Bronsveld, A. Van Rooyen, E.J. Nieuwenhuys, L. Theuns, et al. (1989) Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48 447-454.
224. N. Kasitanon, W. Louthrenoo, W. Sukitawut and R. Vichainun (2002) Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 20 85-91.
225. Y. Alamanos, P.V. Voulgari, M. Papassava, K. Tsamandouraki and A.A. Drosos (2003) Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology (Oxford) 42 1122-1123.
226. D.L. Loriaux, H.J. Ruder, D.R. Knab and M.B. Lipsett (1972) Estrone sulfate, estrone, estradiol and estriol plasma levels in human pregnancy. J Clin Endocrinol Metab 35 887-891.
227. L. Baudino, K. Yoshinobu, N. Morito, S. Kikuchi, L. Fossati-Jimack, B.J. Morley, et al. (2008) Dissection of genetic mechanisms governing the expression of serum retroviral gp70 implicated in murine lupus nephritis. J Immunol 181 2846-2854.
228. P.C. Piotrowski, S. Duriagin and P.P. Jagodzinski (2005) Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies. Clin Rheumatol 24 620-624.
229. M. Okada, H. Ogasawara, H. Kaneko, T. Hishikawa, I. Sekigawa, H. Hashimoto, et al. (2002) Role of DNA methylation in transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus. J Rheumatol 29 1678-1682.
230. H. Ogasawara, T. Naito, H. Kaneko, T. Hishikawa, I. Sekigawa, H. Hashimoto, et al. (2001) Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J Rheumatol 28 533-538.
231. C. Bombardier, D.D. Gladman, M.B. Urowitz, D. Caron and D.H. Chang (1992) the Committee on Prognosis Studies in SLE. (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35 630-640.
232. E.M. Hay, P.A. Bacon, C. Gordon, D.A. Isenberg, P. Maddison, M.L. Snaith, et al. (1993) The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM 86 447-458.
233. S.C. Bae, H.K. Koh, D.K. Chang, M.H. Kim, J.K. Park and S.Y. Kim (2001) Reliability and validity of Systemic Lupus Activity Measure-Revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus 10 405-409.
234. W. Bencivelli, C. Vitali, D.A. Isenberg, J.S. Smolen, M.L. Snaith, M. Sciuto, et al. (1992) Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 10 549-554.
235. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria (2004) The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 50 3418-3426.
236. S. Manzi, E.N. Meilahn, J.E. Rairie, C.G. Conte, T.A. Medsger Jr., L. Jansen-McWilliams, et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145 408-415.
237. J.M. Esdaile, M. Abrahamowicz, T. Grodzicky, Y. Li, C. Panaritis, R. du Berger, et al. (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44 2331-2337.
238. R. Bessant, A. Hingorani, L. Patel, A. MacGregor, D.A. Isenberg and A. Rahman (2004) Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 43 924-929.
239. A.B. Lee, T. Godfrey, K.G. Rowley, C.S. Karschimkus, G. Dragicevic, E. Romas, et al. (2006) Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Intern Med J 36 237-243.
240. A. Schattner and M.H. Liang (2003) The Cardiovascular Burden of Lupus: A complex challenge. Arch Int Med 163 1507-1510.
241. Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program (2002) An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program. Washington, DC: The National Academies Press 1–184
242. V.P. Werth, M. Bashir and W. Zhang (2004) Photosensitivity in Rheumatic diseases. J Investig Dermatol Symp Proc 9(1), 57-63.